BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18445233)

  • 1. Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat.
    Nakatani Y; Sato-Suzuki I; Tsujino N; Nakasato A; Seki Y; Fumoto M; Arita H
    Eur J Neurosci; 2008 May; 27(9):2466-72. PubMed ID: 18445233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.
    Stenfors C; Ross SB
    Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology.
    Sharma A; Castellani RJ; Smith MA; Muresanu DF; Dey PK; Sharma HS
    Int Rev Neurobiol; 2019; 146():1-44. PubMed ID: 31349924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
    Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
    Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone increases extracellular serotonin levels in the frontal cortex of rats.
    Pazzagli M; Giovannini MG; Pepeu G
    Eur J Pharmacol; 1999 Nov; 383(3):249-57. PubMed ID: 10594316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats.
    Rothman RB; Zolkowska D; Baumann MH
    Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
    Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
    Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.
    Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A
    Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    Bel N; Artigas F
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.